More concentrated formulation means fewer injections, and consequently better patient compliance New data presented at the 51st annual meeting of…

Sun Pharma,with market share of 8.01 per cent, continues to top the charts

DRL will pay Hatchtech an upfront amount of $10 million, up to $ 50 million

Merck will invest € 65 million in the laboratory building for R&D discovery technologies at Merck Serono

Spread across 3500 sq feet, the centre aims at facilitating the research and formulation work and consolidating the local assistance…

The products are available to clinical laboratories in Europe for general in vitro diagnostic use Thermo Fisher Scientific has received…

The industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections

Aims to reduce the trauma, high cost of hospitalisation and platelet transfusion